CN216294352U

CN216294352U - Self-expanding biological valve

Info

Publication number: CN216294352U
Application number: CN202122791566.9U
Authority: CN
Inventors: 马琛明; 虞发新; 李加贤; 钦湘; 潘守翔
Original assignee: Nanjing Shengde Medical Technology Co ltd
Current assignee: Nanjing Shengde Medical Technology Co ltd
Priority date: 2021-11-15
Filing date: 2021-11-15
Publication date: 2022-04-15
Anticipated expiration: 2031-11-15

Abstract

The utility model discloses a self-expanding biological valve which comprises a fixed support, an inflow end supporting structure, an outflow end supporting structure and a silica gel suture ring. The stent includes a stretching portion which is broken by an expansion force and then the valve is automatically expanded at a predetermined position. In the deployed state, the inflow and outflow end support structures project outwardly in a radial direction relative to the fixation support for supporting the valve in a predetermined position, continuously exerting an outward and/or downward force on the surrounding tissue, ensuring a reliable fixation of the valve. The valve can be replaced without complex sewing, so that the operation time is reduced, the risk of postoperative complications is reduced, and the valve bracket can be quickly released and reliably fixed by the exquisite design.

Description

Self-expanding biological valve

Technical Field

The utility model belongs to the field of medical appliances, and particularly relates to a self-expandable biological valve which is composed of materials such as nickel-titanium memory alloy and biological tissues. The implant is implanted through surgical operation and is suitable for replacement of diseased valves, and can be applied to aortic valve, pulmonary valve, mitral valve and tricuspid valve positions.

Background

Damage to the heart valve from various pathogenic factors or congenital developmental malformations results in one or more valve anatomies and dysfunctions, manifested as stenosis and/or insufficiency of the valve orifice. Mitral valve and aortic valve are mainly involved (tricuspid valve and pulmonary valve are less involved), and are represented by pathological types such AS Mitral Stenosis (MS), mitral insufficiency (MR), Aortic Stenosis (AS), aortic insufficiency (AR), and combined valvular lesions.

In the prior art, surgical valve replacement is currently favored by minimally invasive, small-incision surgery to reduce patient trauma and speed recovery. Especially, when the original valve calcification cannot be removed, the anatomical position is not well exposed, and the traditional operation method has the problem that the valve is difficult to suture. Moreover, if the problems such as valve leakage and the like are detected in the operation and need to be replaced again, the original suture needs to be carefully removed, so that the operation time is increased, and the incidence rate of complications after the suture is re-sutured is increased because the valve ring is damaged by the suture knot.

In recent years, transcatheter valve implantation is increasingly applied to valvular disease treatment, but the valve is difficult to accurately position in the implantation process, so that the valve implantation position is easy to be inaccurate; for the elderly patients with severe calcification, the original calcification focus is not cut off, so that the valve and the valve ring are difficult to completely joint, and perivalvular leakage is easy to occur; in addition, stent implantation is also prone to displacement conditions, which will also affect the patient's prognosis.

Accordingly, a self-expanding biological valve that is simple to remove and does not mechanically damage the annulus is desired. Meanwhile, the self-expandable biological valve has lower requirements on surgical operation, is safe to implant, facilitates the development of minimally invasive surgery and is also convenient for young cardiac surgeons to master. The self-expandable biological valve implantation technology is feasible and safe, can obviously benefit hemodynamics, can also obviously improve clinical symptoms, and shortens blood flow blocking time and extracorporeal circulation time, so that the death rate and the recurrence rate can be effectively reduced, and the self-expandable biological valve implantation technology has wide adaptation and application prospects.

SUMMERY OF THE UTILITY MODEL

It is therefore an object of the present invention to provide a self-expanding biological valve. Through a special design, the valve replacement can be carried out without complex suture, the extracorporeal circulation time is reduced, the incidence rate of complications of important organs such as heart, brain, liver, kidney and the like after operation is reduced, and potential damage to the aortic root caused by surgical operations such as suture knot and the like is also avoided.

The utility model is realized by the following technical scheme:

the utility model provides a self-expandable biological valve, which comprises a fixed support, an inflow end supporting structure, an outflow end supporting structure and a silica gel suture ring, wherein the inflow end supporting structure is arranged on the fixed support; the fixing support comprises three stretching parts which are respectively positioned at the lower edge position of the junction of the three valve leaflets of the fixing support; the inflow end support structure and the outflow end support structure are arranged on the fixed support, and in a deployment state, the inflow end support structure and the outflow end support structure extend outwards relative to the fixed support in a radial direction and are used for supporting the valve at a preset position, and continuously applying outwards and/or downwards force to surrounding tissues to ensure the reliable fixation of the valve; the silica gel suture ring is arranged at the valve ring plane position on the fixed support, and the valve is sutured with the surrounding human tissue in a three-point positioning manner through the silica gel suture ring, so that the three valve leaflets in the valve are positioned at the proper positions in the valve ring plane.

According to the valve of the present invention, the inflow end support structure and the outflow end support structure are support claspers or corolla.

According to the valve, the supporting buckle structure is made of nickel-titanium alloy materials and is provided with petal-shaped protruding parts which extend outwards in a spreading state; the corolla is composed of uniformly distributed reticular structures, each reticular structure is made of nickel-titanium alloy materials, the outer portion of each reticular structure is wrapped by a skirt edge made of high polymer materials, and the diameter of each reticular structure is larger than that of the valve ring in the unfolded state, so that valve displacement is prevented.

According to the valve of the utility model, the stretching part has a structure with a cross-sectional area smaller than that of other parts of the fixing support, when in use, the stretching part is broken by a radial expansion force applied from the outside, and the diameter of the fixing support can be enlarged and expanded outwards after the stretching part is broken.

According to the valve of the utility model, the stretching part is in a shape of a Chinese character 'ji', and the expected breaking position of the stretching part is positioned at the bending part of the stretching part.

According to the valve of the utility model, the number of the protruding parts of the support buckle is 3 or more than 3, preferably a multiple of 3, and the protruding parts are uniformly distributed on the circumference of the fixing support.

According to the valve of the present invention, the fixing stent is made of metal or polymer material.

According to the valve of the present invention, the inflow end support structure and the outflow end support structure are integrally formed.

When the valve is used for a valve with a small diameter at the inflow end and a large diameter at the outflow end, such as an aortic valve, the inflow end support structure is a corolla, and the outflow end support structure is a support buckle.

When the valve is used for a valve with a larger inflow end and a smaller outflow end, such as a tricuspid valve, the inflow end support structure is a support buckle, and the outflow end support structure is a corolla.

The valve according to the present invention, when used in a valve having a small diameter at both the inflow and outflow ends, such as a pulmonary valve, the inflow and outflow end support structures are corolla.

In accordance with the valve of the present invention, when used with valves having larger diameters at both the inflow and outflow ends, such as the mitral valve, the inflow and outflow end support structures are both support claspers.

The utility model has the beneficial effects that:

the valve has the advantages that the valve can be replaced without complex sewing, the operation time is reduced, the risk of postoperative complications is reduced, and the valve bracket can be quickly released and reliably fixed due to the exquisite design. If the problems of valve leakage and the like are found in the process of operation and need to be replaced again, the self-expandable biological valve is simple to remove, has no mechanical damage to valve rings, has low requirements on surgical operation, is beneficial to carrying out minimally invasive surgery and is convenient for young cardiac surgeons to master. The position where the support breaks the stretching is located at the position of the junction of the fixed support valve leaflets and is completely covered by the polymer skirt, and the test proves that the stent is very safe and reliable.

Drawings

FIG. 1 is a schematic view of an embodiment of the self-expanding biological valve of the present invention for aortic valve replacement;

FIG. 2 is an enlarged partial view of a pull portion of a self-expanding biological valve fixation stent in accordance with an embodiment of the present invention;

FIG. 3 is a schematic view of a self-expanding biological valve implanted in an aorta according to an embodiment of the present invention;

FIG. 4 is a top view of a self-expanding biological valve according to an embodiment of the utility model;

FIG. 5 is a schematic structural diagram of a single-layer fixing stent for a self-expandable biological valve according to an embodiment of the present invention;

FIG. 6 is a schematic structural diagram of a double-layer fixing bracket for a self-expandable biological valve according to an embodiment of the utility model;

FIG. 7 is a schematic view of an outer stent of a self-expandable biological valve double-layered fixation stent according to an embodiment of the utility model;

FIG. 8 is a schematic view of an inner stent of a self-expandable biological valve double-layered fixation stent according to an embodiment of the utility model;

FIG. 9 shows a schematic view of an embodiment of the self-expandable biological valve of the present invention for pulmonary valve replacement;

FIG. 10 shows a schematic view of an embodiment of the self-expanding biological valve of the present invention for mitral valve replacement;

fig. 11 shows a schematic view of an embodiment of the self-expanding biological valve of the present invention for use in tricuspid valve replacement.

Detailed Description

The utility model will be further illustrated with reference to the following specific examples. It should be understood that the examples are only for illustrating the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that various changes or modifications can be made by those skilled in the art after reading the disclosure of the present invention, and such equivalents also fall within the scope of the utility model.

The present embodiment takes a self-expandable biological valve for aortic valve replacement as an example, and the self-expandable biological valve of the present invention is specifically described as follows. As shown in fig. 1, the self-expandable biological valve includes a fixed stent 1, an outflow end support structure 3, a silicone sewing ring 4, and an inflow end support structure 5. The fixing bracket 1 is made of metal or a polymer material, such as PETG and ABS material. The fixed support 1 is provided with three stretching parts 2 (see fig. 2), which are respectively positioned at the lower edge position of the junction of three valve leaflets (not shown in the figure) of the fixed support 1, the stretching parts 2 are in a shape of Chinese character ji, the cross-sectional area of the parts is smaller than that of other parts of the fixed support, so the strength is lower, the parts are easy to break when being subjected to outward radial expansion force, and particularly the bending parts are easy to break.

The fixed support 1 can adopt various structures, and in the embodiment, two schemes of a single-layer support structure and a double-layer support structure are respectively adopted. FIG. 5 shows a single layer scaffold design; figure 6 shows a double layer scaffold design. The outer layer bracket 11 is a short bracket structure (see fig. 7) and made of a metal material, the inner layer bracket 12 is a long bracket structure (see fig. 8) and made of a polymer material, and the two are fixed by sewing to form the fixed bracket 1.

The outflow end support structure 3 adopts a support buckle structure, the outflow end support structure 3 (i.e. support buckle) is arranged on the fixed support 1 and is positioned at the outflow end of the valve, and in the unfolding state, the support buckle extends outwards relative to the fixed support 1 in the radial direction (as shown in fig. 1 and 4) and is in an open petal shape and used for supporting the valve in the aortic sinus, and continuously applies outwards and downwards force to the surrounding tissues to ensure the reliable fixation of the valve. The support button comprises three petal-shaped protruding parts, the number of the protruding parts can be more than three, preferably is a multiple of 3, the protruding parts are uniformly distributed on the circumference of the fixing bracket 1 and are all made of nickel-titanium alloy materials.

The silica gel suture ring 4 is arranged at the valve ring plane position on the fixed support, and the artificial valve is sutured with the surrounding tissues in a three-point positioning way through the silica gel suture ring, so that the accurate positions of the three valve leaflets in the valve ring plane are determined. The inflow end support structure 5 is a crown structure, and its outer portion is wrapped by a skirt (not shown) made of polymer material, and in the deployed state, its diameter is larger than that of the valve ring, and it applies outward force to the surrounding tissue to prevent the valve from being displaced (as shown in fig. 3). The corolla 5 and the support button 3 are manufactured in an integrated forming and integral cutting mode. When the skirt is sewed, the corolla 5 and the support buckle 3 are connected with the fixed bracket 1,

before implantation, the valve is held in a contracted state by tightening the support clasps 3 and the corolla 5 by means of the restraining wire. When the valve is implanted in the aorta at a predetermined position, the support button 3 and the corolla 5 are released naturally by removing the binding wires, and the support button 3 and the corolla 5 can be released rapidly to a desired shape due to the excellent elasticity of the metal nitinol material. As shown in fig. 3, the force of the support button 3 and the crown 5 on the tissue around the valve makes the valve fixed in the desired position and not easy to slide. Then, by extending an expansion device, such as a high-pressure balloon device, into the valve stent and applying a radial expansion force thereto, the stretching portions 2 on the fixed stent 1 are subjected to the expansion force to be broken, and the fixed stent 1 is rapidly expanded in the radial direction along with the breaking of each stretching portion 2 to be closely fitted with the surrounding vascular tissue, thereby ensuring the reliable fixation of the valve.

Fig. 9 shows an embodiment of the use of the self-expandable biological valve of the present invention for pulmonary valve replacement, in which both the inflow end support structure 5 and the outflow end support structure 3 are corolla due to the small diameters of both the inflow end and the outflow end.

Fig. 10 shows an embodiment of the use of the self-expanding biological valve of the present invention for mitral valve replacement, in which both the inflow end support structure 5 and the outflow end support structure 3 are support claspers due to the larger diameter of both the inflow end and the outflow end.

Fig. 11 shows an embodiment of the use of the self-expanding biological valve of the present invention for tricuspid valve replacement, in which the inflow end support structure 5 is a support button and the outflow end support structure 3 is a corolla due to its larger diameter inflow end and smaller diameter outflow end.

Claims

1. A self-expandable biological valve is characterized by comprising a fixed support, an inflow end supporting structure, an outflow end supporting structure and a silica gel suture ring; the fixing support comprises three stretching parts which are respectively positioned at the lower edge position of the junction of the three valve leaflets of the fixing support; the inflow end support structure and the outflow end support structure are arranged on the fixed support, and in a deployment state, the inflow end support structure and the outflow end support structure extend outwards relative to the fixed support in a radial direction and are used for supporting the valve at a preset position, and continuously applying outwards and/or downwards force to surrounding tissues to ensure the reliable fixation of the valve; the silica gel suture ring is arranged at the valve ring plane position on the fixed support, and the valve is sutured with the surrounding human tissue in a three-point positioning manner through the silica gel suture ring, so that the three valve leaflets in the valve are positioned at the proper positions in the valve ring plane.

2. The self-expanding biological valve of claim 1, wherein the inflow and outflow end support structures are support claspers or crowns.

3. The self-expanding biological valve of claim 2, wherein the support clasper structure is made of nitinol material and has outwardly projecting petal-like projections in the deployed state; the corolla is composed of uniformly distributed reticular structures, each reticular structure is made of nickel-titanium alloy materials, the outer portion of each reticular structure is wrapped by a skirt edge made of high polymer materials, and the diameter of each reticular structure is larger than that of the valve ring in the unfolded state, so that valve displacement is prevented.

4. The self-expandable biological valve of claim 3, wherein the stretching portion has a structure having a cross-sectional area smaller than that of the other portion of the stent, and is broken by a radial expansion force applied from the outside when in use, and the stretching portion is broken to expand the diameter of the stent outward.

5. The self-expanding biological valve of claim 4, wherein the stretch is in the shape of a "dog-bone" with the intended break at its bend.

6. The self-expanding biological valve of claim 5, wherein the number of projections of the support clasper is 3 or more than 3, evenly distributed on the circumference of the fixation stent.

7. The self-expanding biological valve of claim 6, wherein the number of projections of the support clasper is a multiple of 3.

8. The self-expanding biological valve of claim 7, wherein the fixation stent is made of metal or polymeric material.

9. The self-expanding biological valve of claim 8, wherein the inflow end support structure and the outflow end support structure are integrally formed.

10. The self-expanding biological valve of any of claims 2-9, wherein the inflow end support structure is a corolla and the outflow end support structure is a support button when used with a valve having a smaller diameter inflow end and a larger diameter outflow end.

11. The self-expanding biological valve of any of claims 2-9, wherein the inflow end support structure is a support button and the outflow end support structure is a corolla when used with a valve having an inflow end with a larger diameter and an outflow end with a smaller diameter.

12. The self-expanding biological valve of any of claims 2-9, wherein the inflow end support structure and the outflow end support structure are both corolla when used with a valve having a small inflow end diameter and a small outflow end diameter.

13. The self-expanding biological valve of any of claims 2-9, wherein the inflow end support structure and the outflow end support structure are both support claspers when used with a valve having an enlarged inflow end diameter and an outflow end diameter.